Abstract The glycan epitopes termed stage-specific embryonic antigens (SSEA) occur on glycoproteins and glycolipids in mammals. However, it is not known whether these epitopes are attached to N-or O-glycans on glycoproteins and/or on glycolipids in the developing mouse embryo.
Introduction
Stage-specific embryonic antigens (SSEA) are present on eggs and preimplantation embryos at specific stages of early mouse development [1] [2] [3] [4] [5] . The epitope of a number of these antigens consists solely of sugar residues. SSEA-1, also known as the Lewis X antigen (Le X ), is Galβ1, 4[Fucα1, 3] GlcNAcβ1,3Galβ1-R, SSEA-3 is Galβ1,3GalNAcβ1, 3Galα1,4Galβ1,4Glcβ1-R, SSEA-4 is sialylated SSEA-3 (NeuAcα2,3Galβ1,3GalNAcβ1,3Galα1,4Galβ1,4Glcβ1-R) and the Lewis Y antigen (Le Y ) is Fucα1,2Galβ1,4 [Fucα1,3]GlcNAcβ1,3Gal-R. Monoclonal antibodies to these antigens were raised about 30 years ago [2] .
The first developmentally regulated SSEA was identified following immunization of mice with F9 embryonal carcinoma cells [1] . The IgM monoclonal antibody (MAb) bound to F9 cells and to mouse embryos, and the antigen it recognized was termed SSEA-1. SSEA-1 is not detected on mouse embryos until the eight-cell compacted stage [1, 6, 7] . Expression continues through morula and early blastocyst but is lost by the late blastocyst stage [1, 7] . The epitope recognized by the SSEA-1 MAb is Galβ1, 4[Fucα1, 3] using isolated oligosaccharides [8] , and by structural analyses of glycolipids [9] . Based on the highly regulated expression pattern of SSEA-1 during blastogenesis, it was proposed that this cell surface antigen might be involved in compaction of the embryo. In fact, compaction was inhibited when four-to eight-cell mouse embryos were incubated with oligosaccharides carrying the SSEA-1 determinant [10, 11] . However, when the α1,3fucosyltransferase Fut9 which adds the fucose of the SSEA-1 epitope was inactivated by targeted mutation, compaction occurred normally in Fut9 −/− mouse embryos, despite a dramatic reduction in the SSEA-1 determinant on late eight-cell embryos [12] . This experiment showed that Fut9 was largely, if not completely, responsible for generating SSEA-1 in mouse embryos, and that the expression of SSEA-1 is not essential for compaction or for mouse development. Nevertheless, expression of SSEA-1 is highly regulated and may have a functional role during blastogenesis. Thus, it is of interest to know whether this antigen is expressed on N-glycans and/or core 1-derived Oglycans of the embryo. Both these glycans are found only on glycoproteins. However, the SSEA-1 determinant, which occurs at the non-reducing terminus of a glycan, occurs on a wide range of glycolipids and glycoproteins in mammalian cells and tissues [3, [13] [14] [15] [16] [17] [18] [19] [20] . SSEA-3 was identified following immunization of rats with four-to eight-cell mouse embryos [2] and was present on glycolipids of human teratocarcinoma cells [21, 22] . Immunoprecipitation of SSEA-3 from mouse embryos revealed numerous proteins by acrylamide gel electrophoresis of the immunoprecipitate [23] . In embryonal carcinoma cells expressing this antigen, tunicamycin treatment markedly decreased proteins immunoprecipitated by the SSEA-3 MAb, indicating that N-glycans express this epitope. SSEA-4 was present on globo-series glycolipids and glycoproteins of teratocarcinoma cells [21, 23] . SSEA-3 and SSEA-4 epitopes are thought to be expressed during oogenesis since they are present on mouse eggs and early embryos, and persist until the late blastocyst stage [24] .
The Le Y epitope was first identified on human red blood cells and monoclonal antibodies were subsequently developed [7, 25] . Le Y is not detected on two to four-cell mouse embryos but is expressed at the morula stage and on blastocysts [7] . Interestingly, MAb against Le Y inhibits mouse blastocyst implantation [26, 27] . The Le Y epitope is expressed on glycolipids and glycoproteins in mammalian cells and tissues.
Each of the glycan epitopes described above is expressed on mouse preimplantation embryos but it is not known if the epitopes are carried on N-or O-glycans of glycoproteins and/or on glycolipids. To begin to investigate this question we developed female mice that ovulate eggs lacking GlcNAcT-I (Mgat1), the glycosyltransferase responsible for converting oligomannose N-glycans to complex or hybrid Nglycans [28] (Fig. 1) . By crossing to Mgat1 +/-males, maternal and zygotic Mgat1 -/-embryos are obtained. These mutant embryos do not express complex or hybrid N-glycans on their glycoproteins and were used to ask if these N-glycans are essential for the expression of the developmentally-regulated glycan antigens SSEA-1, SSEA-3, SSEA-4, or Le Y during mouse embryogenesis. We have also generated female mice that ovulate eggs lacking T-synthase (T-syn), the core 1 β1,3galactosyltransferase necessary for the synthesis of core 1-derived O-glycans [29] . By crossing these females with T-syn +/-males, T-syn -/-embryos are generated. These embryos do not express core 1 or core 2 O-GalNAc glycans ( Fig. 1 ) and were used in this work to determine if these glycans are essential for the synthesis of the developmental antigens described above.
In this paper we use indirect fluorescence microscopy to compare monoclonal antibody binding to SSEAs of Wild type eggs bind PNA but eggs lacking T-syn do not [29] . If sialic acid is added to form core 1 or GlcNAc to form core 2, PNA binding is inhibited. b Mgat1 initiates the synthesis of complex and hybrid N-glycans. The dashed arrow signifies that more than one biochemical step is involved.
Complex N-glycans bind L-PHA. Wild type eggs and embryos bind L-PHA but mutants lacking Mgat1 do not [28, 29, 34] preimplantation mouse embryos that lack complex and hybrid N-glycans or core 1-derived O-glycans. We show that embryos lacking complex N-or core 1-derived O-glycans express each of the four SSEAs similarly to control embryos. Therefore, neither of these classes of glycans is essential for the expression of any of the four developmental antigens.
Materials and methods

Mice
To generate preimplantation mouse embryos that were maternal and zygotic null for the glycosyltransferases Tsynthase or GlcNAcT-I, floxed T-syn or Mgat1 genes were deleted in oocytes. Females of mixed genetic background (predominantly C57BL/6 and 129SvJ), homozygous for Tsyn floxed alleles (T-syn F ) and carrying a Cre recombinase transgene under the control of the oocyte-specific ZP3 promoter (T-syn F/F :ZP3Cre females), ovulate oocytes lacking T-synthase [29] . ZP3 is expressed exclusively in oocytes at the primary follicle stage of development [30] . The ZP3Cre transgenic strain was originally obtained from Dr. Jamey Marth [28] . To obtain embryos lacking core 1-derived O-glycans, T-syn [28, 29] .
The same breeding strategy was used to obtain embryos lacking complex N-glycans. Mgat1 F/F :ZP3Cre females [28] were mated to Mgat1 +/− males and for additional control embryos, Mgat1 F/F females were mated to Mgat1 +/− or Mgat1 +/+ males. Mgat1 F/F :ZP3Cre females were also generated from ZP3Cre strain 93 kindly provided by Dr. Barbara Knowles [31] . Genotyping of parental mice was performed by PCR of tail genomic DNA as previously described [28, 29] .
Egg and embryo collection and preparation
To generate mouse embryos at specific stages of development, females were joined with males and mating was confirmed in the morning by the presence of a vaginal plug. Assuming coitus had taken place at midnight, two-cell embryos were collected at 1.25 days post coitum (pc), fourto eight-cell embryos were collected at 2-2.5 days pc, eight-cell compacted embryos were collected at ∼2.75 days pc, and blastocysts were collected at 3.5-4 days pc.
Embryos were collected into KSOM + AA culture medium (Specialty Media, Phillipsburg, NJ) that had been equilibrated overnight at 37°C in an incubator with 95% CO 2 and 5% air. Pre-blastocyst stage embryos were flushed from oviducts, and blastocysts were flushed from uterine horns using equilibrated medium. Embryos from individual females were examined or, embryos from several females were pooled, and split into groups for sequential lectin and MAb binding.
To obtain ovulated eggs, females were induced to ovulate by intraperitoneal administration of 5IU pregnant mare's serum gonadotrophin (Calbiochem, La Jolla, CA) followed by 5IU human chorionic gonadotrophin (hCG; Sigma, St. Louis, MO) 46-48 h later. Eggs ovulated ∼14 h later and were collected from oviducts 14-16 h post hCG. Oviducts containing ovulated eggs were dissected in M2 medium (Specialty Media) that had been equilibrated overnight at 37°C in an incubator with 95% CO 2 and 5% air. Cumulus masses were released from the oviducts into M2 medium containing 0.3 mg/ml hyaluronidase (Sigma) and protease inhibitors (Roche, Indianapolis, IN). The eggs were incubated in the hyaluronidase for ∼5 min to remove cumulus cells and then washed in M2 medium.
The zona pellucida was removed from eggs and embryos by brief immersion in Tyrodes acid and washing in M2 or KSOM + AA medium respectively before fixation in 2% paraformaldehyde for 1 h at room temperature. Eggs and embryos were then washed in phosphate buffered saline containing 3% bovine serum albumin (PBS/BSA) by transferring through three sequential droplets under mineral oil. Consecutive washing through three droplets under mineral oil was used for all egg/embryo medium transfers from the initial blocking stage onwards. If embryos were to be stored before further antibody incubation, as was often the case for negative control embryos, they were stored at 4°C in PBS/BSA. Embryos of two to four cells were included as negative controls for SSEA-1 and Le Y expression, and late stage blastocysts were included as negative controls for SSEA-3 and SSEA-4 expression [7, 24] .
Lectin binding
Eggs and embryos were phenotyped based on their lectin binding properties [28, 29, 32] . To block non-specific lectin binding sites, eggs and embryos were incubated in PBS/BSA for 1 h at room temperature before incubation in lectin. Complex and hybrid N-glycans were detected by incubation of eggs and embryos in 20 μg/ml Phaseolus vulgaris leukoagglutinin conjugated to fluorescein isothiocyanate (L-PHA-FITC; Vector Labs, Burlingame, CA) for 1 h at room temperature. Core 1-derived O-glycans were detected by incubation of embryos with 20 μg/ml peanut agglutinin conjugated to FITC (PNA-FITC; Vector Labs) for 1 h at room temperature. All steps from the start of lectin incubation with the exception of egg/embryo transfer were performed in the dark to minimize photobleaching.
Antibody binding
Following incubation in lectin, eggs and embryos were washed in PBS/BSA by three drop transfer and incubated in MAb for 1 h at room temperature. After primary antibody, eggs and embryos were washed, transferred to the appropriate secondary antibody and incubated for 1 h at room temperature. Eggs and embryos were then washed and photographed in the last of the three droplets.
SSEA-1/Le X was detected using the SSEA-1 MAb in conditioned medium diluted at 1/100 prepared from hybridoma cells kindly provided by Dr. Barbara Knowles [1] . After washing in PBS/BSA embryos were incubated in tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse IgM at 1/100 in PBS/BSA (Southern Biotech, Birmingham, AL). Eggs and embryos were examined for SSEA-3 and SSEA-4 expression using MAbs [21] in undiluted hybridoma cell conditioned medium. The monoclonal antibodies to SSEA3 and SSEA4 developed by B. B. Knowles and D. Solter were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242 (MC-631 for SSEA-3 and MC-813-70 for SSEA-4). After washing, SSEA-4 MAb binding was detected using rhodamine-conjugated donkey anti-mouse IgG at 1/100 in PBS/BSA (Jackson Labs), and SSEA-3 MAb binding was detected using TRITC-conjugated goat anti-rat IgG at 1/ 100 (Jackson Labs). Le Y expression was detected using clone F3 monoclonal antibody at 1/50 dilution in PBS/ BSA (Calbiochem), washing in PBS/BSA and incubation 
Fluorescence microscopy
Fluorescence microscopy was performed with an inverted Olympus fluorescence microscope using filters for the detection of fluorescein or rhodamine. Control and mutant eggs and embryos were photographed in the last wash droplet under oil with the phase pictures and different exposures taken in exactly the same order to ensure that photobleaching was minimal and equivalent. Within each experiment, the phase picture was taken using controls first, followed by increasing exposures (0.125 up to 2 s) of FITC fluorescence and then by increasing exposures (0.125 up to 2 s) of TRITC fluorescence, with the same sequence then repeated with mutant embryos. The exposures shown in the figures were selected as the level of fluorescence that allowed embryos with no binding to be just visible-generally a 1 s exposure.
Results
Identification of control and mutant eggs and embryos
In order to directly compare control and mutant eggs and embryos for developmental antigen expression, they were obtained from several control and mutant females for analysis in the same experiment. Embryos at a stage that should not bind the MAb were added to each group. Control embryos are distinguished from T-syn mutant embryos by their different abilities to bind PNA (Fig. 1) , as previously described for ovulated eggs [29] . PNA binding was strong in most control embryos (Fig. 2b) . However, two-to four-cell control embryos did not bind PNA as well as embryos at later stages (Fig. 2b) . This may be because expression of T-synthase is reduced at the twoto four-cell stage, or due to the addition of sialic acid to core 1 or of GlcNAc to form core 2 O-glycans (Fig. 1) . Importantly however, late eight-cell compacted wild type (Fig. 2b) , whereas T-syn mutant embryos at the same stage did not bind PNA (Fig. 2e) . The fact that heterozygous compacted embryos present with mutant embryos in Fig. 2e did not bind PNA as well as control compacted embryos in Fig. 2b most likely reflects a delay in paternal T-syn gene activation. Thus, heterozygous embryos derived from mutant females receive their active Tsyn gene following fertilization, and translation from paternal transcripts may not occur until the four-to eight-cell or the morula stage as was shown for β-catenin and E-cadherin, respectively [33] . Nevertheless, eight-cell compacted T-syn −/− mutant embryos were readily identified by their lack of PNA binding (circled in Fig. 2e) .
Wild type eggs and embryos that express Mgat1 synthesize complex N-glycans that bind the lectin L-PHA [28, 34] (Fig. 1) . It can be seen in Fig. 3 that mixed wild type and heterozygous control embryos bound L-PHA similarly (Fig. 3b) and mutant embryos were readily identified by their reduced L-PHA binding (circled in Fig. 3e ).
Expression of SSEA-1 in mouse embryos lacking core 1-derived O-glycans
The embryos shown in Fig. 2a, d were compared for binding of the MAb against SSEA-1. Embryos collected at the two-to four-cell stage when SSEA-1 is not expressed, were mixed with eight-cell control and mutant compacted embryos. It can be seen in Fig. 2c, c' and f, f' (dashed arrows) that two-to four-cell embryos did not express SSEA-1 and provided appropriate negative controls for background levels of SSEA-1 MAb binding. By contrast, eight-cell compacted control embryos bound SSEA-1 very well (Fig. 2c, c') . Since the expression of SSEA-1 is tightly regulated, those embryos that exhibited less binding of SSEA-1 or PNA may be at a slightly earlier or later stage of development. T-syn mutant eight-cell compacted embryos, identified on the basis of their lack of PNA binding (circled in Fig. 2e, f) , also bound the SSEA-1 MAb well (Fig. 2f, f −/− embryos are circled. a'-f' The area marked by each dotted square in a-f is magnified. Images are at the same magnification and the same exposure. Solid arrows indicate PNA-negative mutant embryos. The images are representative of 3 independent experiments with 2 eggs and 21 four-to eight-cell embryos, half of the total generated by 6 control females, 3 eggs and 21 four-to eight-cell embryos, half of the total generated by 6 T-syn mutant females of PNA-negative embryos (Fig. 2f, f' ) was similar to wild type embryos (Fig. 2c, c' ). These images are representative of 20 compacted embryos collected from mutant females. Thus, core 1-derived O-glycans are not essential for the expression of SSEA-1. Embryos lacking core 1-derived O-glycans must therefore express the SSEA-1 epitope predominantly on N-glycans of glycoproteins and/ or on glycolipids.
T-syn +/+ or T-syn +/-T-syn +/-or T-syn -/-T-syn +/+ or T-syn +/-T-syn +/-or T-syn -/-
Expression of SSEA-1 in mouse embryos lacking complex and hybrid N-glycans Embryos lacking complex and hybrid N-glycans, identified by their lack of L-PHA binding (circled in Fig. 3e , solid arrows in e'), were compared to control embryos at the eight-cell compacted stage for binding of the SSEA-1 MAb. As observed in Fig. 2 , control embryos bound the SSEA-1 MAb well at the eight-cell compacted stage but not at the two-to four-cell stage (Fig. 3c, c' , dashed arrows). Mgat1 mutant embryos also bound the SSEA-1 MAb well (circled in Fig. 3e, f, solid arrows in e' and f') . The smaller eight-cell compacted mutant embryo had somewhat aberrant morphology which was to be expected in embryos generated from Mgat1 −/− eggs of which ∼50% are retarded in development [28] . Overall, in comparisons of 12 compacted eight-cell embryos from control and 8 from mutant females, SSEA-1 MAb binding was similar between control and mutant. Thus, complex or hybrid N-glycans are not essential for the expression of the SSEA-1.
Expression of SSEA-3 in mouse embryos lacking core 1-derived O-glycans SSEA-3 is present on eggs and preimplantation embryos until the blastocyst stage [23, 24] . To determine if core 1-derived O-glycans are substantial carriers of the SSEA-3 epitope, four-to eight-cell embryos were collected. Control embryos and blastocysts were PNA-positive (Fig. 4b, b' ) while Tsyn −/− embryos from T-syn
:ZP3Cre females were PNAnegative (circled in Fig. 4e, f) . Control embryos at the four-to eight-cell stage bound the SSEA-3 MAb well but fluorescence was greatly reduced at the late blastocyst stage which constituted the negative control for the SSEA-3 MAb (Fig. 4c, f, dashed arrows) . T-syn mutant embryos (circled in Fig. 4e, f) bound the SSEA-3 MAb similarly to control embryos as shown in Fig. 4f , f' (solid arrows). T-syn mutant eggs also bound the SSEA-3 MAb equivalently to control eggs (not shown). Thus SSEA-3 is not expressed at observable levels on core 1-derived O-glycans in eggs or early embryos, suggesting that SSEA-3 is predominantly expressed either on complex N-glycans and/or on glycolipids.
Expression of SSEA-3 in mouse eggs and embryos lacking complex and hybrid N-glycans
To investigate a role for complex N-glycans in the expression of SSEA-3 during embryogenesis, eggs and embryos were obtained from Mgat1 F/F :ZP3Cre females mated to Mgat1 +/− males. Since both SSEA-3 and SSEA-4 are expressed on ovulated eggs and embryos until the blastocysts stage [24] , Mgat1 −/− ovulated eggs were used for analyzing the expression of these two antigens because Mgat1 mutant females have low fertility. Eggs could be readily collected after superovulation whereas few embryos were obtained post mating [28] .
Results shown in Fig. 5 are for eggs after removal of the zona pellucida. It can be seen in Fig. 5b that wild type ovulated eggs bound substantially more L-PHA than mature blastocysts which served as the negative control for SSEA-3 MAb binding (Fig. 5b, c, dashed arrows) . SSEA-3 was well expressed on wild type eggs (Fig. 5c, c') . Mgat1 mutant eggs bound L-PHA poorly (Fig. 5e, e' ) but bound the SSEA-3 MAb similarly to wild type eggs (Fig. 5f, f') . The control blastocysts did not bind the SSEA-3 MAb (Fig. 5c, f, MAb. PNAnegative embryos are circled in e and f and identified by solid arrows in e' and f'. a'-f' The area marked by each dotted square in a-f is magnified. Images are at the same magnification and the same exposure. Solid arrows point to PNA-negative early embryos. Images are representative of 3 experiments with 2 eggs and 19 four-to eightcell embryos, half of the total generated by six control females and 4 eggs and 22 four-to eight-cell embryos, half of the total generated by 6 mutant T-syn females separate experiment in which all four early embryos obtained from a Mgat1 +/− male were tested, each embryo bound the SSEA-3 MAb similarly to control embryos (not shown). Therefore SSEA-3 was expressed well in eggs and early embryos lacking complex N-glycans and they are not the major carriers of the SSEA-3 epitope during oogenesis or embryogenesis.
Expression of SSEA-4 in mouse embryos lacking core 1-derived O-glycans SSEA-4 is expressed on eggs and preimplantation embryos until the blastocyst stage in a pattern similar to SSEA-3 [21, 24] . To determine if the SSEA-4 epitope is carried on core 1-derived O-glycans, embryos lacking these glycans were generated by crossing females ovulating T-syn −/− eggs with T-syn +/− males. T-syn mutant embryos at the four-to eightcell stage were identified by their low PNA binding (circled in Fig. 6e, f) . They bound the SSEA-4 MAb well (Fig. 6f,  f', solid arrows) . Mature negative control blastocysts bound only low levels of SSEA-4 MAb (Fig. 6c, c' , f, f', dashed arrows). Control embryos and T-syn mutant embryos were similar in their SSEA-4 MAb binding, as were control and mutant eggs (Fig. 6c, c', f, f') . Therefore, core 1-derived Oglycans are not essential for the expression of the SSEA-4 epitope during oogenesis or on early mouse embryos.
Expression of SSEA-4 in mouse eggs and embryos lacking complex and hybrid N-glycans Eggs collected from Mgat1 mutant females lack complex and hybrid N-glycans and did not bind L-PHA (Fig. 7e) . Control eggs bound L-PHA as expected (Fig. 7b) , and exhibited much higher fluorescence than the negative control blastocyst in Fig. 7e . The control blastocyst bound very low amounts of SSEA-4 MAb (Fig. 7f, dashed The Le Y antigen is expressed on blastocysts prior to implantation [18, 27] . Therefore blastocysts generated from control and T-syn mutant females were compared for binding of a MAb against Le Y . Earlier stage embryos that do not express Le Y were included as negative controls (Fig. 8c, c', f, dashed arrows) . Control blastocysts bound the Le Y MAb well (Fig. 8c, c' ) and so did T-syn mutant blastocysts (Fig. 8f, f' , solid arrows) identified by their lack of PNA binding (circled in Fig. 8e, e' (Fig. 9c, c' , f, f', dashed arrows). Blastocysts collected from Mgat1 mutant females and lacking L-PHA binding (circled in Fig. 9e, f) bound the Le Y MAb as well as control blastocysts (Fig. 9c , c' compared to f and f', solid arrows). As previously observed, ∼50% of the blastocysts generated by Mgat1 F/F :ZP3Cre females (Fig. 9d ) had irregular morphology [28] , however this did not alter the stage-specific expression of Le Y (Fig. 9f) . Therefore the Le Y epitope is not predominantly expressed on the N-glycans or O-glycans (shown above) of glycoproteins. 
Discussion
Determining molecular parameters of preimplantation mouse embryos is a challenge due to the difficulties of obtaining sufficient numbers of staged embryos. Structural analyses of glycans of the zona pellucida have been performed but required very large numbers of mice [35] . Thus most evidence concerning structural features of mammalian developmental antigens have been obtained by indirect approaches. In this work we have examined the expression of developmentally regulated SSEAs of the mouse embryo by characterizing the expression of glycan antigens recognized by monoclonal antibodies in maternal and zygotic mutant embryos that are missing a key enzyme necessary for the synthesis of entire classes of N-or O-glycans. The female mice used to generate mutant embryos have been phenotypically characterized in some depth previously [28, 29, 32 ] (Williams and Stanley, submitted). Mutant embryos were identified by their inability to bind lectins that recognize complex N-glycans or core 1 O-glycans and characterized for MAb binding by indirect immunofluorescence. MAb specificity was demonstrated from background binding to embryos at particular stages of development known from previous work not to express the relevant antigen (reviewed in [7, 24] ). Therefore, the dynamic range of the experiments was quite large.
Interestingly, despite the fact that there is much evidence that each SSEA examined is expressed on glycoproteins in cells and tissues, we observed no marked reduction in MAb binding in mutant eggs or embryos lacking complex N-or core 1-derived O-glycans. Thus when T-synthase was absent and eggs or embryos did not express core 1-derived Oglycans, eight-cell compacted embryos bound SSEA-1 MAb, eggs and early embryos bound SSEA-3 and SSEA-4 MAbs, and mature blastocysts bound the Le Y MAb equivalently to control embryos at the same stage. Therefore, core 1-derived O-glycans on glycoproteins are not essential for the expression of these SSEAs. A similar conclusion was reached with eggs and staged embryos lacking complex and hybrid Nglycans. It would have been very helpful to have examined embryos lacking both classes of glycan together. Unfortunately, however, the fertility of females conditionally mutant for both T-syn and Mgat1 is extremely low [29] , and it was not possible to obtain staged embryos from these females for these experiments. Nevertheless, the fact that mutant and control MAb binding was equivalent for each SSEA in both of the single conditional mutants suggests that SSEA-1, SSEA-3, SSEA-4 and Le Y are predominantly expressed on glycolipids in preimplantation mouse embryos. This question can be examined directly by crossing female mice conditionally mutant for glucosylceramide synthase [36] with ZP3Cre recombinase transgenic mice and determining SSEA expression on null embryos at different stages of development.
While the data presented in this work predict that potentially no glycoproteins carry the SSEA glycan epitopes examined, previous experiments have reported that several glycoproteins from mouse embryos labeled by 125 I and lactoperoxidase are immunoprecipitated by the SSEA-3 MAb [23] . Evidence that N-glycans may carry the SSEA-3 epitope comes from the fact that treatment with tunicamycin reduced the expression of SSEA-3 on fucoselabeled glycoproteins from an embryonal carcinoma line [23] . While similar experiments have not been reported for SSEA-1, SSEA-4 or Le Y , it is known that at least the SSEA-1 [37] and Le Y epitopes are expressed on N-glycans of numerous glycoproteins. Both SSEA-3 and SSEA-4 epitopes are commonly found on globo-series glycolipids [21] and are predicted to be expressed on glycolipids of the mouse embryo [22] . The data we present here are consistent with this prediction. Thus, in summary, maternal and zygotic embryos that do not express complex or hybrid Nglycans or core 1-derived O-glycans, express the glycan epitopes recognized by the SSEA-1, SSEA-3, SSEA-4 and Le Y MAbs at levels equivalent to control embryos. Therefore neither class of glycan is essential for the expression of these SSEAs by cells of the mouse embryo.
